Skip to main content

Day: November 20, 2019

Kiniksa Pharmaceuticals to Present at the 2nd Annual Evercore ISI HealthCONx Conference

HAMILTON, Bermuda, Nov. 20, 2019 (GLOBE NEWSWIRE) — Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) announced today that it will present at the 2nd Annual Evercore ISI HealthCONx Conference on Wednesday, December 4th, 2019 at 3:30 p.m. Eastern Time at the Four Seasons Hotel in Boston, MA.A live webcast of Kiniksa’s presentation will be accessible through the Investors & Media section of the company’s website at www.kiniksa.com. A replay of the webcast will be available on Kiniksa’s website for 14 days following the conference.About KiniksaKiniksa is a biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Kiniksa has a pipeline of product candidates across various stages of development,...

Continue reading

Adverum Biotechnologies to Participate in Piper Jaffray’s 31st Annual Healthcare Conference

MENLO PARK, Calif., Nov. 20, 2019 (GLOBE NEWSWIRE) — Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, today announced that  the company will present at Piper Jaffray’s 31st Annual Healthcare Conference on Wednesday, December 4, 2019 at 11:00 am EST.A live audio webcast will be accessible under Events and Presentations in the Investors section of the company’s website. The archived audio webcast will be available on the Adverum website following the presentation for 30 days.About Adverum Biotechnologies, Inc.Adverum Biotechnologies (Nasdaq: ADVM) is a clinical-stage gene therapy company targeting unmet medical needs for serious ocular and rare diseases. Adverum is evaluating its novel gene therapy candidate, ADVM-022, as a one-time,...

Continue reading

Five Below, Inc. Announces Third Quarter Fiscal 2019 Earnings Release and Conference Call Date

PHILADELPHIA, PA, Nov. 20, 2019 (GLOBE NEWSWIRE) — Five Below, Inc. (NASDAQ:FIVE), the trend-right, high-quality extreme-value retailer for tweens, teens and beyond, today announced that its financial results for the third quarter of 2019 will be released after market close on Wednesday, December 4, 2019. The company will host a conference call at 4:30 p.m. Eastern Time to discuss the financial results.Investors and analysts interested in participating in the call are invited to dial 1-412-902-6753 approximately 10 minutes prior to the start of the call. A live audio webcast of the conference call will be available online at investor.fivebelow.com.A taped replay of the conference call will be available within two hours of the conclusion of the call and can be accessed online or by dialing 412-317-0088 and entering the access code...

Continue reading

County Bancorp, Inc. Declares Quarterly Dividend

MANITOWOC, Wis., Nov. 20, 2019 (GLOBE NEWSWIRE) — County Bancorp, Inc. (NASDAQ: ICBK), the parent company for Investors Community Bank, announced that on November 19, 2019 its Board of Directors declared a quarterly cash dividend of $0.05 per share. The dividend will be payable on December 20, 2019 to shareholders of record as of December 6, 2019.  “We are very pleased with the improvement we have seen in our credit portfolio this quarter as well as our record quarterly earnings,” stated Tim Schneider, President of the Company and CEO of the Bank.  “This dividend reflects the continued confidence we have in ICBK and our strategy.”About County Bancorp, Inc. County Bancorp, Inc., a Wisconsin corporation and registered bank holding company founded in May 1996, and our wholly-owned subsidiary Investors Community Bank, a Wisconsin-chartered...

Continue reading

Molecular Templates, Inc. Announces Proposed Public Equity Offering

AUSTIN, Texas, Nov. 20, 2019 (GLOBE NEWSWIRE) — Molecular Templates, Inc. (Nasdaq: MTEM) (the “Company” or “Molecular”), a clinical-stage biopharmaceutical company focused on the discovery and development of the Company’s proprietary engineered toxin bodies (ETBs), which are differentiated, targeted, biologic therapeutics for cancer, today announced that it has commenced an underwritten public offering of its common stock and newly designated Series A convertible preferred stock. Molecular also intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of common stock offered in the public offering on the same terms and conditions. All of the shares in the offering are to be sold by Molecular.Molecular intends to use the net proceeds from the offering, together with its existing cash and...

Continue reading

Capital Southwest Supports LKCM Headwater’s Refinancing of Relevant Rental

DALLAS, Nov. 20, 2019 (GLOBE NEWSWIRE) — Capital Southwest Corporation (“Capital Southwest”) (Nasdaq:CSWC), an internally managed business development company focused on providing flexible financing solutions to support the acquisition and growth of middle market businesses, announced today that it supported LKCM Headwater Investments (“LKCM”), the private investment arm of Luther King Capital Management, in its recent refinancing of ICS Distribution, LLC d/b/a Relevant Rental (“Relevant” or the “Company”). Capital Southwest led the financing transaction and serves as administrative agent on the term loan.“We are grateful to partner again with LKCM and finance a complicated transaction which carved the rental business out of its former parent company,” said Douglas Kelley, Managing Director of Capital Southwest. Ryan...

Continue reading

Nuance Announces Fourth Quarter and Fiscal Year 2019 Results

Revenue growth at high end of range, beating operating margin and EPS guidanceStrength in Dragon Medical cloud offerings, exceeding full-year ARR guidance with 38% growthSuccessful completion of October 1st Automotive spinExited year as a simpler, more growth-focused companyBURLINGTON, Mass., Nov. 20, 2019 (GLOBE NEWSWIRE) — Nuance Communications, Inc. (NASDAQ: NUAN) today announced financial results for its fourth quarter and fiscal year ended September 30, 2019.ASC 606 Q4 2019 Performance Summary (1)GAAP revenue of $470.7 million and GAAP earnings per diluted share of $0.37.Non-GAAP revenue of $472.0 million and non-GAAP earnings per diluted share of $0.33.ASC 605 Q4 2019 Performance Summary (1)ASC 605 revenue of $487.8 million and earnings per diluted share of $0.42.Non-GAAP revenue of $489.3 million and non-GAAP earnings per...

Continue reading

HD Supply Holdings, Inc. Announces Fiscal 2019 Third-Quarter Earnings Release Date and Conference Call

ATLANTA, Nov. 20, 2019 (GLOBE NEWSWIRE) — HD Supply Holdings, Inc. (Nasdaq: HDS), one of the largest industrial distributors in North America, today announced that the company is planning to release its third-quarter 2019 results via press release on Tuesday, December 10th, at 6 a.m. (ET) to be followed by a conference call at 8 a.m. (ET). The conference call and presentation materials can be accessed via webcast by logging on from the Investor Relations section of the company’s website at hdsupply.com. The online replay will remain available for a limited time following the call.To learn more about HD Supply, please visit the company’s website at hdsupply.com. HD Supply uses its website as a channel of distribution for material company information. Financial and other material information regarding HD Supply is routinely...

Continue reading

Optinose Announces Proposed Public Offering of Common Stock

YARDLEY, Pa., Nov. 20, 2019 (GLOBE NEWSWIRE) — Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that it and certain selling stockholders intend to offer and sell shares of its common stock in an underwritten public offering. In addition, Optinose is expected to grant the underwriters an option for a period of 30 days to purchase up to an additional 15% of the total number of shares to be offered at the public offering price, less the underwriting discount. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed.Optinose intends to use the net proceeds of the offering for working capital and general corporate purposes. Optinose will not receive any proceeds...

Continue reading

Green Thumb Industries (GTI) Reports Increased Third Quarter Revenue of $68 Million and Adjusted Operating EBITDA of $14.1 Million

Third quarter revenue increased 296% year-over-yearExpect to generate over $200 million in total revenue for fiscal year 2019Retail expansion on pace with four new Rise™ stores opened during the quarter, bringing total new stores opened year-to-date to 14Ample liquidity and financial flexibility to support growth strategyCHICAGO and VANCOUVER, British Columbia, Nov. 20, 2019 (GLOBE NEWSWIRE) — Green Thumb Industries Inc. (“GTI” or the “Company”) (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer packaged goods company and owner of Rise™ and Essence retail stores, today reported its financial results for the third quarter ended September 30, 2019.  All currency is in U.S. dollars, unless noted otherwise.Financial HighlightsThird quarter 2019 revenue increased 296% year-over-year to $68.0 million. Quarter-over-quarter...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.